Results 221 to 230 of about 7,712,957 (388)

Clinical outcomes in patients with chronic renal dysfunction following percutaneous coronary intervention: a report from the New York state angioplasty registry

, 2002
Robert M. Minutello, Eric T. Chou, Mun K. Hong, Selwyn Wong   +3 more
openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Diversity of patients and outcome in Surgical Intensive Care Unit, King Chulalongkorn memorial Hospital: a preliminary report

, 2002
P. Seiprachittichai
openalex   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Patient-reported outcomes for remote and in-person visits for genetic counseling in adult neurology. [PDF]

J Genet Couns
Paul RA, Babaian N, Brzozowski M, Baldwin A, Johnson K, Azage M, Bardakjian T, Tropea TF, Dratch L.   +8 more
europepmc   +1 more source

Task Force Report of the Patient-Reported Outcomes Harmonization Group: Too Much Harmony, Not Enough Melody?

, 2003
William R. Lenderking
openalex   +1 more source

Poster 210 successful outcome of a pediatric patient with eastern equine encephalitis, despite a high morbidity and mortality rate associated with the disease: A case report. Clinton Faulk, MD (Pitt County Mem Hosp, Greenville, NC); Billy Smith, MD; Daniel Moore, MD, e-mail: cjmfaulk@yahoo.com [PDF]

, 2004

openalex   +1 more source

Oh, the Places We’ll Go: Patient-Reported Outcomes and Electronic Health Records

Patient, 2018
Sarah G. Gensheimer, A. Wu, C. Snyder, PRO-EHR Users’ Guide Steering Group, PRO-EHR Users’ Guide Steering Group   +4 more
semanticscholar   +1 more source